Lifecore Biomedical Inc（LFCR）價格預測LFCRLifecore Biomedical Inc

Alphio's LFCR stock price prediction model matches the current Lifecore Biomedical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.47 (+0.47%). The 1-week path is $6.12 (-5.04%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Lifecore Biomedical Inc (LFCR) is currently trading at $6.39, which is slightly below the analyst price target of $6.50. The stock has a forward P/E of 8.67, indicating potential value, but it has experienced a year-to-date decline of 17.44%. The recent acquisition news provides a premium of 49.5% over the previous closing price, which could enhance shareholder value if performance milestones are met. However, the company has reported significant net losses, with a net income of -$7.1 million in Q2 2026, posing a risk to recovery. Therefore, while there are positive catalysts, the ongoing losses suggest a cautious approach is warranted.

Lifecore Biomedical Inc (LFCR) last closed at $6.4400001, gaining +0.31%. These facts feed the 1-day and 1-week LFCR price prediction above.